Rapport Therapeutics, Inc. (RAPP) cash on hand

Cash · fiscal 2025
$490.54M

Rapport Therapeutics, Inc. (RAPP) held cash of $490.54M at the end of fiscal 2025 (December 31, 2025). That is 60.7% higher than the $305.28M of fiscal 2024. Figures as of 17 Nov 2026, 23:20 UTC, from Yahoo Finance.

Key facts

Cash, fiscal 2025
$490.54M
Change on fiscal 2024
+60.7%
Highest on record
$490.54Mfiscal 2025
Lowest on record
$31.16Mfiscal 2022
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Amounts are in USD. Figures, not advice.

Rapport Therapeutics, Inc. cash on hand, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $490.54M in fiscal 2025 and the lowest $31.16M in fiscal 2022.

History · 4 fiscal years

Cash by fiscal year

Rapport Therapeutics, Inc. cash on hand, year by year

Rapport Therapeutics, Inc. (RAPP) cash on hand by fiscal year
Fiscal yearCashChangeYear ended
2025$490.54M 60.7% up
2024$305.28M 107.0% up
2023$147.48M 373.3% up
2022$31.16M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Cash is the cash, cash equivalents and short-term investments on the balance sheet at the fiscal year-end, shown for the fiscal years the market data feed covers because the older SEC record counts cash and equivalents alone.

How to read it

Cash is the cushion that pays for bad years, buybacks and acquisitions; compare it with total debt to see whether the company is a net borrower.

More on RAPP

Rapport Therapeutics, Inc., figure by figure

Rapport Therapeutics, Inc. (RAPP) overview: price, valuation and scorecard

Rapport Therapeutics, Inc. cash on hand: questions and answers

How much cash does Rapport Therapeutics, Inc. have?

Rapport Therapeutics, Inc. (RAPP) held cash of $490.54M at the end of fiscal 2025 (December 31, 2025). That is 60.7% higher than the $305.28M of fiscal 2024.

What are the highest and lowest cash figures on record for Rapport Therapeutics, Inc.?

Across the 4 fiscal years on record (2022–2025), the highest was $490.54M in fiscal 2025 and the lowest $31.16M in fiscal 2022.

How is Rapport Therapeutics, Inc.'s cash calculated?

Cash is the cash, cash equivalents and short-term investments on the balance sheet at the fiscal year-end, shown for the fiscal years the market data feed covers because the older SEC record counts cash and equivalents alone.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Rapport Therapeutics, Inc. (RAPP) cash on hand”, data as of 17 November 2026. https://funkfolio.com/stock/RAPP/cash

Underlying data: Yahoo Finance.